Lauren Richards lost her mom Rochelle Richards to ovarian cancer earlier this year. Lauren set out on a mission to make a difference in her community and to honor her mom’s journey. On April 22nd, Lauren hosted a benefit concert called “OVARYact” at Will’s Pub in Orlando, FL. The concert had an admission fee of $10 and included food, fun, a silent auction and performances by some local bands. Lauren shared: “I feel like this event made a huge difference to me and the community. It brought me some closure I was seeking and I’ve never been so proud of myself for accomplishing something. I know my mom is very proud, wherever she is.” Lauren was glad to know that she empowered other women with knowledge on the signs and symptoms of ovarian cancer and hopes to make this an annual event. Lauren is still tallying all the money raised but has reported that the event made over $6,000 for OCRFA! The local paper, the Orlando Sentinel published her story in the paper, which can be found here.
Related Topics
The Overview: April 2026
Accelerating the Mission: OCRA President & CEO Audra Moran Named a Crain’s 2026 Notable Leader in Health Care Ovarian Cancer Research Alliance (OCRA) is proud to share that President and CEO Audra Moran has been named a Crain’s New York Business 2026 Notable Leader in Health Care—an annual recognition honoring executives whose leadership, innovation, and … Continued
April Programs: New Offerings, Fresh Topics, and More
April is a full month at OCRA, with several new programs joining our ongoing lineup of workshops, educational sessions, and community events. Whether you’re looking for practical guidance, clinical information, or simply a chance to connect and create, there’s something here for you. New and Expanded Programs Advanced Care Planning Workshop Series April 6, 13, … Continued
Cool Hand Frank Names OCRA Featured Cause for March
Cool Hand Frank, a digital publication that spotlights nonprofits making a difference, has named Ovarian Cancer Research Alliance (OCRA) its featured cause for March 2026, spotlighting OCRA’s work in advancing ovarian and gynecologic cancer research and supporting patients and their loved ones. The publication cited a deeply personal connection to the cause, with the author … Continued